PON-arylesterase activity was significantly lower in AD (mean ± SD: 88 ± 26 kU/L) or VaD (87 ± 25 kU/L) compared to CONTROLS (101 ± 27 kU/L, p < 0.001 for all differences) (Figure 1). The gene discussed is PON1; the disease is Alzheimer disease.